Leadership Transition at Viralgen: A New Era for AAV Gene Therapy #Spain #San_Sebastián #Viralgen #AAV_Gene_Therapy #AskBio
@newsen.bsky.social
third-news.comLeadership Transition at Viralgen: A New Era for AAV Gene TherapyViralgen's CEO Jimmy Vanhove is stepping down, with Angela Ochoa Chico set to take the lead. This transition signals significant growth and innovation in AAV gene therapy.